238 related articles for article (PubMed ID: 27174227)
1. Non-Sink Dissolution Conditions for Predicting Product Quality and In Vivo Performance of Supersaturating Drug Delivery Systems.
Sun DD; Wen H; Taylor LS
J Pharm Sci; 2016 Sep; 105(9):2477-2488. PubMed ID: 27174227
[TBL] [Abstract][Full Text] [Related]
2. Haste Makes Waste: The Interplay Between Dissolution and Precipitation of Supersaturating Formulations.
Sun DD; Lee PI
AAPS J; 2015 Nov; 17(6):1317-26. PubMed ID: 26338234
[TBL] [Abstract][Full Text] [Related]
3. Supersaturating drug delivery systems: fast is not necessarily good enough.
Augustijns P; Brewster ME
J Pharm Sci; 2012 Jan; 101(1):7-9. PubMed ID: 21953470
[TBL] [Abstract][Full Text] [Related]
4. Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability?
Brouwers J; Brewster ME; Augustijns P
J Pharm Sci; 2009 Aug; 98(8):2549-72. PubMed ID: 19373886
[TBL] [Abstract][Full Text] [Related]
5. Solution-mediated phase transformation: significance during dissolution and implications for bioavailability.
Greco K; Bogner R
J Pharm Sci; 2012 Sep; 101(9):2996-3018. PubMed ID: 22213419
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of gastrointestinal drug supersaturation and precipitation: strategies and issues.
Bevernage J; Brouwers J; Brewster ME; Augustijns P
Int J Pharm; 2013 Aug; 453(1):25-35. PubMed ID: 23194883
[TBL] [Abstract][Full Text] [Related]
7. Biorelevant dissolution testing and physiologically based absorption modeling to predict in vivo performance of supersaturating drug delivery systems.
Thakore SD; Sirvi A; Joshi VC; Panigrahi SS; Manna A; Singh R; Sangamwar AT; Bansal AK
Int J Pharm; 2021 Sep; 607():120958. PubMed ID: 34332060
[TBL] [Abstract][Full Text] [Related]
8. Investigation of novel supersaturating drug delivery systems of chlorthalidone: The use of polymer-surfactant complex as an effective carrier in solid dispersions.
França MT; Nicolay Pereira R; Klüppel Riekes M; Munari Oliveira Pinto J; Stulzer HK
Eur J Pharm Sci; 2018 Jan; 111():142-152. PubMed ID: 28964949
[TBL] [Abstract][Full Text] [Related]
9. Trends in the Assessment of Drug Supersaturation and Precipitation In Vitro Using Lipid-Based Delivery Systems.
Stillhart C; Kuentz M
J Pharm Sci; 2016 Sep; 105(9):2468-2476. PubMed ID: 26935881
[TBL] [Abstract][Full Text] [Related]
10. Physical chemistry of supersaturated solutions and implications for oral absorption.
Taylor LS; Zhang GGZ
Adv Drug Deliv Rev; 2016 Jun; 101():122-142. PubMed ID: 27013254
[TBL] [Abstract][Full Text] [Related]
11. Mathematical model to analyze the dissolution behavior of metastable crystals or amorphous drug accompanied with a solid-liquid interface reaction.
Hirai D; Iwao Y; Kimura SI; Noguchi S; Itai S
Int J Pharm; 2017 Apr; 522(1-2):58-65. PubMed ID: 28235625
[TBL] [Abstract][Full Text] [Related]
12. Mathematical Models to Explore Potential Effects of Supersaturation and Precipitation on Oral Bioavailability of Poorly Soluble Drugs.
Kleppe MS; Forney-Stevens KM; Haskell RJ; Bogner RH
AAPS J; 2015 Jul; 17(4):902-17. PubMed ID: 25851513
[TBL] [Abstract][Full Text] [Related]
13. Combining in vitro dissolution/permeation with microdialysis sampling: Capabilities and limitations for biopharmaceutical assessments of supersaturating drug formulations.
Holzem FL; Jensen IH; Petrig Schaffland J; Stillhart C; Brandl M; Bauer-Brandl A
Eur J Pharm Sci; 2023 Sep; 188():106533. PubMed ID: 37480963
[TBL] [Abstract][Full Text] [Related]
14. Prediction of oral absorption of cinnarizine--a highly supersaturating poorly soluble weak base with borderline permeability.
Berlin M; Przyklenk KH; Richtberg A; Baumann W; Dressman JB
Eur J Pharm Biopharm; 2014 Nov; 88(3):795-806. PubMed ID: 25195981
[TBL] [Abstract][Full Text] [Related]
15. Overcoming sink limitations in dissolution testing: a review of traditional methods and the potential utility of biphasic systems.
Phillips DJ; Pygall SR; Cooper VB; Mann JC
J Pharm Pharmacol; 2012 Nov; 64(11):1549-59. PubMed ID: 23058042
[TBL] [Abstract][Full Text] [Related]
16. Dynamic dissolution: a step closer to predictive dissolution testing?
McAllister M
Mol Pharm; 2010 Oct; 7(5):1374-87. PubMed ID: 20698545
[TBL] [Abstract][Full Text] [Related]
17. Compromised in vitro dissolution and membrane transport of multidrug amorphous formulations.
Alhalaweh A; Bergström CAS; Taylor LS
J Control Release; 2016 May; 229():172-182. PubMed ID: 27006280
[TBL] [Abstract][Full Text] [Related]
18. Population Balance Model for Simulation of the Supersaturation-Precipitation Behavior of Drugs in Supersaturable Solid Forms.
Ozaki S
J Pharm Sci; 2019 Jan; 108(1):260-267. PubMed ID: 30092242
[TBL] [Abstract][Full Text] [Related]
19. Effect of Extent of Supersaturation on the Evolution of Kinetic Solubility Profiles.
Han YR; Lee PI
Mol Pharm; 2017 Jan; 14(1):206-220. PubMed ID: 28043130
[TBL] [Abstract][Full Text] [Related]
20. Developing dissolution testing methodologies for extended-release oral dosage forms with supersaturating properties. Case example: Solid dispersion matrix of indomethacin.
Tajiri T; Morita S; Sakamoto R; Mimura H; Ozaki Y; Reppas C; Kitamura S
Int J Pharm; 2015 Jul; 490(1-2):368-74. PubMed ID: 26022889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
